Relief Therapeutics Holding AG (RLFTF)

[Dash82]

There are no goal posts being moved. It’s completely normal for clinical trial to continue enrollment beyond target while awaiting approval. What else would they do, stop treating people for several months in the meantime?

This is good news that enrollment moving along so quickly. IF it turns out that expansion is needed, we’ll be in good position to reach that target with minimal delay, but just the fact that enrollment is continuing is not at all indicative that expansion WILL be needed for approval.